Close Menu

NEW YORK – ProciseDx and Lumiphore today announced that they have inked an agreement to incorporate Lumiphore's metal luminescent reporter technology into ProciseDx's rapid, quantitative point-of-care diagnostic tests.

Under the agreement, San Diego-based ProciseDx has the exclusive worldwide rights to use Lumiphore's reporter technology in its diagnostic tests.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.